338 related articles for article (PubMed ID: 15156176)
21. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y
Oncogene; 2005 Jun; 24(28):4477-85. PubMed ID: 15856017
[TBL] [Abstract][Full Text] [Related]
22. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages.
Himes SR; Cronau S; Mulford C; Hume DA
Oncogene; 2005 Aug; 24(34):5278-86. PubMed ID: 16007221
[TBL] [Abstract][Full Text] [Related]
23. RUNX genes, neoplasia, and cleidocranial dysplasia.
Cohen MM
Am J Med Genet; 2001 Dec; 104(3):185-8. PubMed ID: 11754042
[No Abstract] [Full Text] [Related]
24. RUNX1 translocations in malignant hemopathies.
De Braekeleer E; Férec C; De Braekeleer M
Anticancer Res; 2009 Apr; 29(4):1031-7. PubMed ID: 19414342
[TBL] [Abstract][Full Text] [Related]
25. RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53.
Wotton SF; Blyth K; Kilbey A; Jenkins A; Terry A; Bernardin-Fried F; Friedman AD; Baxter EW; Neil JC; Cameron ER
Oncogene; 2004 Jul; 23(32):5476-86. PubMed ID: 15133495
[TBL] [Abstract][Full Text] [Related]
26. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes.
Ito Y
Adv Cancer Res; 2008; 99():33-76. PubMed ID: 18037406
[TBL] [Abstract][Full Text] [Related]
27. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.
Huang G; Shigesada K; Ito K; Wee HJ; Yokomizo T; Ito Y
EMBO J; 2001 Feb; 20(4):723-33. PubMed ID: 11179217
[TBL] [Abstract][Full Text] [Related]
28. Runx proteins are involved in regulation of CD122, Ly49 family and IFN-gamma expression during NK cell differentiation.
Ohno S; Sato T; Kohu K; Takeda K; Okumura K; Satake M; Habu S
Int Immunol; 2008 Jan; 20(1):71-9. PubMed ID: 18003603
[TBL] [Abstract][Full Text] [Related]
29. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
Fliegauf M; Stock M; Berg T; Lübbert M
Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
[TBL] [Abstract][Full Text] [Related]
30. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD
Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
[TBL] [Abstract][Full Text] [Related]
31. Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3.
Iwatsuki K; Tanaka K; Kaneko T; Kazama R; Okamoto S; Nakayama Y; Ito Y; Satake M; Takahashi S; Miyajima A; Watanabe T; Hara T
Oncogene; 2005 Feb; 24(7):1129-37. PubMed ID: 15592512
[TBL] [Abstract][Full Text] [Related]
32. Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.
Wotton S; Stewart M; Blyth K; Vaillant F; Kilbey A; Neil JC; Cameron ER
Cancer Res; 2002 Dec; 62(24):7181-5. PubMed ID: 12499254
[TBL] [Abstract][Full Text] [Related]
33. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
[TBL] [Abstract][Full Text] [Related]
34. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
35. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression.
Stein GS; Lian JB; van Wijnen AJ; Stein JL; Montecino M; Javed A; Zaidi SK; Young DW; Choi JY; Pockwinse SM
Oncogene; 2004 May; 23(24):4315-29. PubMed ID: 15156188
[TBL] [Abstract][Full Text] [Related]
36. The RUNX genes: gain or loss of function in cancer.
Blyth K; Cameron ER; Neil JC
Nat Rev Cancer; 2005 May; 5(5):376-87. PubMed ID: 15864279
[TBL] [Abstract][Full Text] [Related]
37. SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo.
Chakraborty S; Sinha KK; Senyuk V; Nucifora G
Oncogene; 2003 Aug; 22(34):5229-37. PubMed ID: 12917624
[TBL] [Abstract][Full Text] [Related]
38. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells.
Egawa T; Tillman RE; Naoe Y; Taniuchi I; Littman DR
J Exp Med; 2007 Aug; 204(8):1945-57. PubMed ID: 17646406
[TBL] [Abstract][Full Text] [Related]
39. Physical and functional interactions between STAT5 and Runx transcription factors.
Ogawa S; Satake M; Ikuta K
J Biochem; 2008 May; 143(5):695-709. PubMed ID: 18296717
[TBL] [Abstract][Full Text] [Related]
40. Control of RUNX2 isoform expression: the role of promoters and enhancers.
Stock M; Otto F
J Cell Biochem; 2005 Jun; 95(3):506-17. PubMed ID: 15838892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
